1-methyl-3-isobutylxanthine has been researched along with Bone Diseases, Metabolic in 2 studies
1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.
Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nuttall, ME | 1 |
| Patton, AJ | 1 |
| Olivera, DL | 1 |
| Nadeau, DP | 1 |
| Gowen, M | 1 |
| Waki, Y | 1 |
| Horita, T | 1 |
| Miyamoto, K | 1 |
| Ohya, K | 1 |
| Kasugai, S | 1 |
2 other studies available for 1-methyl-3-isobutylxanthine and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders.
Topics: 1-Methyl-3-isobutylxanthine; Adipocytes; Alkaline Phosphatase; Animals; Apolipoproteins; Bone Diseas | 1998 |
Effects of XT-44, a phosphodiesterase 4 inhibitor, in osteoblastgenesis and osteoclastgenesis in culture and its therapeutic effects in rat osteopenia models.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Body Weight; Bone Density | 1999 |